Martine Zimmermann
Director/Board Member presso INVENTIVA
Patrimonio netto: 167 034 $ in data 31/03/2024
Profilo
Martine Zimmermann is an Independent Director at Ligand Pharmaceuticals, Inc. and Inventiva SA. She is also the SVP and Head of Regulatory Affairs and R&D Quality at Ipsen Biopharmaceuticals, Inc. Previously, she worked as a Director at Caelum Biosciences, Inc. and as the Senior VP and Head of Global Regulatory Affairs at Alexion Pharmaceuticals, Inc. She holds a doctorate degree from both the University of Strasbourg and Louis Pasteur University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 22/09/2023 | 2 285 ( 0.01% ) | 167 034 $ | 31/03/2024 |
Posizioni attive di Martine Zimmermann
| Società | Posizione | Inizio |
|---|---|---|
| INVENTIVA | Director/Board Member | 16/04/2021 |
| LIGAND PHARMACEUTICALS INCORPORATED | Director/Board Member | 26/09/2023 |
| Ipsen Biopharmaceuticals, Inc. | General Counsel | - |
Precedenti posizioni note di Martine Zimmermann
| Società | Posizione | Fine |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | General Counsel | 01/02/2023 |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Director/Board Member | 01/01/2021 |
Formazione di Martine Zimmermann
| University of Strasbourg | Doctorate Degree |
| Louis Pasteur University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| INVENTIVA | Health Technology |
| Aziende private | 3 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| Ipsen Biopharmaceuticals, Inc. | |
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Martine Zimmermann
